Related Experiment Videos
Quantification of optic nerve blood flow changes using magnetic resonance imaging
C Prünte1, J Flammer, R Markstein
1University Eye Clinic, Basel, Switzerland.
Investigative Ophthalmology & Visual Science
|January 1, 1995
Summary
Magnetic resonance imaging (MRI) can quantify optic nerve microcirculation changes. Dopaminergic drugs, like SDZ GLC-756, significantly increase optic nerve blood flow, offering new insights into ocular blood flow regulation.
Area of Science:
- Ophthalmology
- Neuroscience
- Medical Imaging
Background:
- Optic nerve microcirculation is crucial for vision.
- Quantifying changes in optic nerve blood flow is challenging.
- Pharmacological modulation of ocular blood flow is of therapeutic interest.
Purpose of the Study:
- To assess the utility of magnetic resonance imaging (MRI) for quantifying pharmacologically induced alterations in optic nerve microcirculation.
- To investigate the effects of specific dopaminergic agents on optic nerve blood flow.
Main Methods:
- T2-weighted MRI sequences were employed in a rat model.
- Blood flow in the optic nerve (anterior and posterior regions) and frontal cortex was calculated.
- Experiments involved control (placebo, timolol) and drug (SDZ GLC-756) administration in a double-blind manner.
Main Results:
- Baseline blood flow values were established for optic nerve regions and frontal cortex.
- Placebo and timolol did not induce significant changes in optic nerve blood flow.
- SDZ GLC-756, a dopaminergic agent, markedly increased blood flow in both anterior (238%) and posterior (87%) optic nerve segments.
Conclusions:
- MRI is a viable tool for quantifying optic nerve blood flow.
- Dopaminergic substances demonstrably enhance optic nerve perfusion.
- These findings may have implications for understanding and treating conditions affecting optic nerve health.